Statins, fracture risk, and bone remodeling.

Luisetto, G; Camozzi, V

Luisetto, G; Camozzi, V.

Affiliation

Luisetto G; Department of Medical and Surgical Sciences, Division of Endocrionlogy, University of Padua, via Ospedale 105, 35128 Padua, Italy. giovanni.luisetto@unipd.it

J Endocrinol Invest ; 32(4 Suppl): 32-7, 2009.

Article in En | MEDLINE | ID: mdl-19724164

Subject(s)

Bone Remodeling/drug effects; Fractures, Bone/etiology; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Animals; Bone and Bones/drug effects; Bone and Bones/metabolism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology; Models, Biological; Risk Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Remodeling / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Fractures, Bone Type of study: Clinical_trials / Etiology_studies / Evaluation_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: J Endocrinol Invest Year: 2009 Document type: Article

Search on Google

XML

PubMed Links